140 related articles for article (PubMed ID: 15765143)
1. Licking latency with licorice.
Cohen JI
J Clin Invest; 2005 Mar; 115(3):591-3. PubMed ID: 15765143
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.
Curreli F; Friedman-Kien AE; Flore O
J Clin Invest; 2005 Mar; 115(3):642-52. PubMed ID: 15765147
[TBL] [Abstract][Full Text] [Related]
3. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
4. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
5. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.
Bentz GL; Lowrey AJ; Horne DC; Nguyen V; Satterfield AR; Ross TD; Harrod AE; Uchakina ON; McKallip RJ
PLoS One; 2019; 14(5):e0217578. PubMed ID: 31125383
[TBL] [Abstract][Full Text] [Related]
6. Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency.
Gray KS; Allen RD; Farrell ML; Forrest JC; Speck SH
J Virol; 2009 Jan; 83(1):314-28. PubMed ID: 18971285
[TBL] [Abstract][Full Text] [Related]
7. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
Brown HJ; McBride WH; Zack JA; Sun R
Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
[TBL] [Abstract][Full Text] [Related]
8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
9. Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses.
Hayward SD; Liu J; Fujimuro M
Sci STKE; 2006 May; 2006(335):re4. PubMed ID: 16705130
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
[TBL] [Abstract][Full Text] [Related]
11. Licorice and cancer.
Wang ZY; Nixon DW
Nutr Cancer; 2001; 39(1):1-11. PubMed ID: 11588889
[TBL] [Abstract][Full Text] [Related]
12. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
Cho HJ; Yu F; Sun R; Lee D; Song MJ
Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency.
Moser JM; Upton JW; Gray KS; Speck SH
J Virol; 2005 Apr; 79(8):5227-31. PubMed ID: 15795307
[TBL] [Abstract][Full Text] [Related]
14. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases.
Asahi-Ozaki Y; Sato Y; Kanno T; Sata T; Katano H
J Infect Dis; 2006 Mar; 193(6):773-82. PubMed ID: 16479510
[TBL] [Abstract][Full Text] [Related]
17. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
Zawilinska B; Kosinska A; Lenart M; Kopec J; Piatkowska-Jakubas B; Skotnicki A; Kosz-Vnenchak M
Acta Biochim Pol; 2008; 55(4):693-9. PubMed ID: 19015775
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality.
Thorley-Lawson DA; Duca KA; Shapiro M
Trends Immunol; 2008 Apr; 29(4):195-201. PubMed ID: 18328785
[TBL] [Abstract][Full Text] [Related]
19. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
Rechsteiner MP; Bernasconi M; Berger C; Nadal D
Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
[TBL] [Abstract][Full Text] [Related]
20. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
